receptor, fibroblast growth factor, type 2 - CISMeF
Receptor, fibroblast growth factor, type 2MeSH Descriptor
Preferred Label : receptor, fibroblast growth factor, type 2;
MeSH definition : A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform
is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second
isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS
and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation
of the gene for fibroblast growth factor receptor 2 can result in craniosynostotic
syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME).; A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN
I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed
in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform
is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR
7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor
receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON
SYNDROME).;
A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform
is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second
isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS
and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation
of the gene for fibroblast growth factor receptor 2 can result in craniosynostotic
syndromes (e.g., APERT SYNDROME; and CROUZON SYNDROME). A fibroblast growth factor receptor which contains three extracellular IMMUNOGLOBULIN
I-SET DOMAINS and is expressed as two isoforms. One receptor isoform is expressed
in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform
is expressed mainly by EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR
7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor
receptor 2 can result in craniosynostotic syndromes (e.g., APERT SYNDROME; and CROUZON
SYNDROME).